Shopping Cart
- Remove All
- Your shopping cart is currently empty
17-oxo-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic acid is a metabolite of lipoxygenase-mediated oxidation of DHA that is produced endogenously by aspirin-enhanced COX-2 activity. It has been shown to activate Nrf2-dependent antioxidant gene expression, to act as a PPARγ agonist (EC50 = ~200 nM), and to inhibit pro-inflammatory cytokine and nitric oxide production at biological concentration ranges (5-25 μM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 μg | $123 | 35 days | |
50 μg | $230 | 35 days | |
100 μg | $430 | 35 days | |
250 μg | $950 | 35 days |
Description | 17-oxo-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic acid is a metabolite of lipoxygenase-mediated oxidation of DHA that is produced endogenously by aspirin-enhanced COX-2 activity. It has been shown to activate Nrf2-dependent antioxidant gene expression, to act as a PPARγ agonist (EC50 = ~200 nM), and to inhibit pro-inflammatory cytokine and nitric oxide production at biological concentration ranges (5-25 μM). |
Molecular Weight | 342.479 |
Formula | C22H30O3 |
Cas No. | 1233715-28-0 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | Ethanol: 20 mg/mL DMSO: 10 mg/mL DMF: 15 mg/mL |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.